Skip to content

Exploratory study on the salt discharging effect of intake Mekabu or Mozuku.

Exploratory study on the salt discharging effect of intake Mekabu or Mozuku. - Exploratory study on the salt discharging effect of intake Mekabu or Mozuku.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040665
Enrollment
90
Registered
2020-06-05
Start date
2020-06-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake 35g (once a day) of Mekabu daily for a week. Participants take test food before one of three meals. Intake 40g (once a day) of Mozuku daily for a week. Participants take test food before one

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document. 2.Japanese who are 20 years old or more and under 65 years old. 3.Persons who highly tend to take salt at pre-questionnaire.

Exclusion criteria

Exclusion criteria: 1.Persons who have chronic illness, receiving medication, have a serious disease history. 2.Persons who are allergic to the test food. 3.Persons who usually take a large amount of test food. 4.Persons who usually take medicine, specified health food, healthy food. 5.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam. 6.Persons who were judged as inappropriate for subjects by the principal investigator. 7.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding.

Design outcomes

Primary

MeasureTime frame
Salt intake ( urinary sodium, urinary creatinine, body weight, body height, age) at the beginning of the study or after the intake for a week.

Secondary

MeasureTime frame
Questionnaire at the beginning of the study or after the intake for a week.

Countries

Japan

Contacts

Public ContactYukari Kobayashi

Healthcare Systems Co., Ltd. Sales Planning Department

kobayashi@hc-sys.jp070-1450-5470

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026